Novel roles of nuclear angiotensin receptors and signaling mechanisms

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 302, Issue 5, 2012, Pages

  Gwathmey, Tanya M ^a   Alzayadneh, Ebaa M ^a   Pendergrass, Karl D ^a   Chappell, Mark C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

ACE2; Angiotensin converting enzyme; AT 1; AT 2; AT 7; Kidney; Neprilysin; Nuclei; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANGIOTENSIN[1-7]; ANGIOTENSIN[1-7] RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SODIUM PROTON EXCHANGE PROTEIN 3; TRANSFORMING GROWTH FACTOR; UNCLASSIFIED DRUG;

BINDING SITE; CARDIOVASCULAR DISEASE; CELL NUCLEUS; DISEASE COURSE; ELECTROLYTE BALANCE; ENDOPLASMIC RETICULUM; FLOW CYTOMETRY; FLUID BALANCE; HUMAN; HYPERTENSION; KIDNEY; KIDNEY CORTEX; KIDNEY INJURY; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL NUCLEUS; DISEASE MODELS, ANIMAL; HUMANS; HYPERTENSION; KIDNEY; MICE; RATS; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM; SHEEP; SIGNAL TRANSDUCTION; WATER-ELECTROLYTE BALANCE;

EID: 84857856222     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00525.2011     Document Type: Review

References (107)

1. Abadir PM, Foster DB, Crow M, Cooke CA, Rucker JJ, Jain A, Smith BJ, Burks TN, Cohn RD, Fedarko NS, Carey RM, O'Rourke B, Walston JD. Identification and characterization of a functional mito-chondrial angiotensin system. Proc Natl Acad Sci USA 108: 14849-51484, 2011.
2. Benigni A, Corna D, Zoja C, Sonzogni A, Latini R, Salio M, Conti S, Rottoli D, Longaretti L, Cassis P, Morigi M, Coffman TM, Remuzzi G. Disruption of the Ang II type 1 receptor promotes longevity in mice. J Clin Invest 119: 524-530, 2009.
3. Boivin B, Chevalier D, Villeneuve LR, Rousseau E, Allen BG. Functional endothelin receptors are present on nuclei in cardiac ventricular myocytes. J Biol Chem 278: 29153-29163, 2003.
4. Booz GW, Conrad KM, Hess AL, Singer HA, Baker KM. Angioten-sin-II-binding sites on hepatocyte nuclei. Endocrinology 130: 3641-3649, 1992.
5. Bradford CN, Ely DR, Raizada MK. Targeting the vasoprotective axis of the renin-angiotensin system: a novel strategic approach to pulmonary hypertensive therapy. Curr Hypertens Rep 12: 212-219, 2010.
6. Braun-Menendez E, Fasciolo JC, Leloir LF, Munoz JM. The substance causing renal hypertension. J Physiol 98: 283-298, 1940.
7. Brown D, Breton S, Ausiello DA, Marshansky V. Sensing, signaling and sorting events in kidney epithelial cell physiology. Traffic 10: 275-284, 2009.
8. Bumpus FM, Green AA, Page IH. Purification of angiotonin. J Biol Chem 210: 287-294, 1954.
9. Camargo de Andrade MC, Di Marco GS, de Paulo CT, V, Mortara RA, Sabatini RA, Pesquero JB, Boim MA, Carmona AK, Schor N, Casarini DE. Expression and localization of N-domain ANG I-convert-ing enzymes in mesangial cells in culture from spontaneously hypertensive rats. Am J Physiol Renal Physiol 290: F364-F375, 2006.
10. Campbell DJ. Endogenous angiotensin II levels and the mechanism of action of angiotensin-converting enzyme inhibitors and angiotensin receptor type 1 antagonists. Clin Exp Pharmacol Physiol Suppl 3: S125-S131, 1996.
11. Cao W, Zhou QG, Nie J, Wang GB, Liu Y, Zhou ZM, Hou FF. Albumin overload activates intrarenal renin-angiotensin system through protein kinase C and NADPH oxidase-dependent pathway. J Hypertens 29: 1411-1421, 2011.
12. Carey RM. Cardiovascular and renal regulation by the angiotensin type 2 receptor. The AT2 receptor comes of age. Hypertension 45: 840-844, 2005.
13. Cervenka L, Vaneckova I, Huskova Z, Vanourkova Z, Erbanova M, Thumova M, Skaroupkova P, Opocensky M, Maly J, Chabova VC, Tesar V, Burgelova M, Viklicky O, Teplan V, Zelizko M, Kramer HJ, Navar LG. Pivotal role of angiotensin II receptor subtype 1A in the development of two-kidney, one-clip hypertension: study in angiotensin II receptor subtype 1A knockout mice. J Hypertens 26: 1379-1389, 2008.
14. Chappell MC. Emerging evidence for a functional angiotensin-convert-ing enzyme 2-angiotensin-(1-7) mas receptor axis; more than regulation of blood pressure? Hypertension 50: 596-599, 2007.
15. Chappell MC, Brosnihan KB, Diz DI, Ferrario CM. Identification of angiotensin-(1-7) in rat brain: evidence for differential processing of angiotensin peptides. J Biol Chem 264: 16518-16523, 1989.
16. Contag SA, Bi J, Chappell MC, Rose JC. Developmental effect of antenatal exposure to betamethasone on renal angiotensin II activity in the young adult sheep. Am J Physiol Renal Physiol 298: F847-F856, 2010.
17. Cook JL, Mills SJ, Naquin R, Alam J, Re RN. Nuclear accumulation of the AT1 receptor in a rat vascular smooth muscle cell line: effects upon signal transduction and cellular proliferation. J Mol Cell Cardiol 40: 696-707, 2006.
18. Cook JL, Mills SJ, Naquin RT, Alam J, Re RN. Cleavage of the angiotensin II type 1 receptor and nuclear accumulation of the cytoplas-mic carboxy-terminal fragment. Am J Physiol Cell Physiol 292: C1313- C1322, 2007.
19. Cook JL, Singh A, Deharo D, Alam J, Re RN. Expression of a naturally occurring angiotensin AT1 receptor cleavage fragment elicits caspase-activation and apoptosis. Am J Physiol Cell Physiol 301: C1175-C1185, 2011.
20. Cook JL, Zhang Z, Re RN. In vitro evidence for an intracellular site of angiotensin action. Circ Res 89: 1138-1146, 2001.
21. da Silveira KD, Pompermayer Bosco KS, Diniz LR, Carmona AK, Cassali GD, Bruna-Romero O, de Sousa LP, Teixeira MM, Santos RA, Simoes Silva AC, and Ribeiro Vieira MA. ACE2-angiotensin-(1-7)-Mas axis in renal ischaemia/reperfusion injury in rats. Clin Sci (Lond) 119: 385-394, 2010.
22. Dalziel SR, Walker NK, Parag V, Mantell C, Rea HH, Rodgers A, Harding JE. Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomized controlled trial. Lancet 365: 1856-1862, 2005.
23. Dauer WT, Worman HJ. The nuclear envelope as a signaling node in development and disease. Dev Cell 17: 626-638, 2009.
24. DeMello WC. Is an intracellular renin-angiotensin system involved in control of cell communication in heart? J Cardiovasc Pharmacol 23: 640-646, 1994.
25. Diz DI. Future directions in cardiovascular pharmacology: examples from the renin-angiotensin system. Mol Interv 8: 222-225, 2008.
26. Diz DI. Lewis K. Dahl memorial lecture: the renin-angiotensin system and aging. Hypertension 52: 37-43, 2008.
27. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robinson K, Jeyaseelan R, Breitbart RE, Acton S. A novel angiotensin-converting enzyme-related carboxypepti-dase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 87: E1-E9, 2000.
28. Ferder L, Inserra F, Romano L, Ercole L, Pszenny V. Effects of angiotensin-converting enzyme inhibition on mitochondrial number in the aging mouse. Am J Physiol Cell Physiol 265: C15-C18, 1993.
29. Filipeanu CM, Henning RH, De Zeeuw D, Nelemans A. Intracellular Angiotensin II and cell growth of vascular smooth muscle cells. Br J Pharmacol 132: 1590-1596, 2001.
30. Gallagher PE, Ferrario CM, Tallant EA. MAP kinase/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides. Am J Physiol Cell Physiol 295: C1169-C1174, 2008.
31. Garabelli PJ, Modrall JG, Penninger JM, Ferrario CM, Chappell MC. Distinct roles for angiotensin converting enzyme 2 and carboxy-peptidase A in the processing of angiotensins in the murine heart. Exp Physiol 93: 613-621, 2008.
32. Geraldes P, King GL. Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res 106: 1319-1331, 2010.
33. Gilliam-Davis S, Payne VS, Kasper SO, Tommasi EN, Robbins ME, Diz DI. Long-term AT1 receptor blockade improves metabolic function and provides renoprotection in Fischer-344 rats. Am J Physiol Heart Circ Physiol 293: H1327-H1333, 2007.
34. Gironacci MM, Adamo HP, Corradi G, Santos RA, Ortiz P, Carret-ero OA. Angiotensin (1-7) induces MAS receptor internalization. Hypertension 58: 176-181, 2011.
35. Gobeil F Jr., Zhu T, Brault S, Geha A, Vazquez-Tello A, Fortier A, Barbaz D, Checchin D, Hou X, Nader M, Bkaily G, Gratton JP, Heveker N, Ribeiro-da-Silva A, Peri K, Bard H, Chorvatova A, Orleans-Juste P, Goetzl EJ, Chemtob S. Nitric oxide signaling via nuclearized endothelial nitric-oxide synthase modulates expression of the immediate early genes iNOS and mPGES-1. J Biol Chem 281: 16058-16067, 2006.
36. Gonzalez-Villalobos R, Klassen RB, Allen PL, Johanson K, Baker CB, Kobori H, Navar LG, Hammond TG. Megalin binds and internalizes angiotensin-(1-7). Am J Physiol Renal Physiol 290: F1270-F1275, 2006.
37. Gonzalez-Villalobos R, Klassen RB, Allen PL, Navar LG, Hammond TG. Megalin binds and internalizes angiotensin II. Am J Physiol Renal Physiol 288: F420-F427, 2005.
38. Gorin Y, Block K, Hernandez J, Bhandari B, Wagner B, Barnes JL, Abboud HE. Nox4 NAD(P)H oxidase mediates hypertrophy and fi-bronectin expression in the diabetic kidney. J Biol Chem 280: 39616-39626, 2005.
39. Gorin Y, Ricono JM, Kim NH, Bhandari B, Choudhury GG, Abboud HE. Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells. Am J Physiol Renal Physiol 285: F219-F229, 2003.
40. Gwathmey TM, Pendergrass KD, Reid SD, Rose JC, Diz DI, Chap-pell MC. Angiotensin-(1-7)-angiotensin-converting enzyme 2 attenuates reactive oxygen species formation to angiotensin II within the cell nucleus. Hypertension 55: 166-171, 2010.
41. Gwathmey TM, Shaltout HA, Pendergrass KD, Pirro NT, Figueroa JP, Rose JC, Diz DI, Chappell MC. Nuclear angiotensin II type 2 (AT2) receptors are functionally linked to nitric oxide production. Am J Physiol Renal Physiol 296: F1484-F1493, 2009.
42. Gwathmey TM, Shaltout HA, Rose JC, Diz DI, Chappell MC. Glucocorticoid-induced fetal programming alters the functional complement of angiotensin receptor subtypes within the kidney. Hypertension 57: 620-626, 2011.
43. Gwathmey TM, Westwood BM, Pirro NT, Tang L, Rose JC, Diz DI, Chappell MC. Nuclear angiotensin-(1-7) receptor is functionally coupled to the formation of nitric oxide. Am J Physiol Renal Physiol 299: F983-F990, 2010.
44. Hilenski LL, Clempus RE, Quinn MT, Lambeth JD, Griendling KK. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 24: 677-683, 2004.
45. Hoch NE, Guzik TJ, Chen W, Deans T, Maalouf SA, Gratze P, Weyand C, Harrison DG. Regulation of T-cell function by endoge-nously produced angiotensin II. Am J Physiol Regul Integr Comp Physiol 296: R208-R216, 2009.
46. Hunyady L. Molecular mechanisms of angiotensin II receptor internalization. J Am Soc Nephrol 10 Suppl 11: S47-S56, 1999.
47. Huskova Z, Kramer HJ, Vanourkova Z, Thurnova M, Maly J, Opocensky M, Skaroupkova P, Kolsky A, Vernerova Z, Cervenka L. Effects of dietary salt load and salt depletion on the courses of hypertension and angiotensin II levels in male and female heterozygous Ren-2 transgenic rats. Kidney Blood Press Res 30: 45-55, 2007.
48. Imig JD, Navar GL, Zou LX, O'Reilly KC, Allen PL, Kaysen JH, Hammond TG, Navar LG. Renal endosomes contain angiotensin peptides, converting enzyme, and AT(1A) receptors. Am J Physiol Renal Physiol 277: F303-F311, 1999.
49. Kaschina E, Grzesiak A, Li J, Foryst-Ludwig A, Timm M, Rompe F, Sommerfeld M, Kemnitz UR, Curato C, Namsolleck P, Tschope C, Hallberg A, Alterman M, Hucko T, Paetsch I, Dietrich T, Schnack-enburg B, Graf K, Dahlof B, Kintscher U, Unger T, Steckelings UM. Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction? Circulation 118: 2523-2532, 2008.
50. Kumar R, Singh VP, Baker KM. The intracellular renin-angiotensin system: a new paradigm. Trends Endocrinol Metab 18: 208-214, 2007.
51. Kuroda J, Nakagawa K, Yamasaki T, Nakamura K, Takeya R, Kuribayashi F, Imajoh-Ohmi S, Igarashi K, Shibata Y, Sueishi K, Sumimoto H. The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells. Genes Cells 10: 1139-1151, 2005.
52. Kurtz TW, Klein U. Next generation multifunctional angiotensin receptor blockers. Hypertens Res 32: 826-834, 2009.
53. Lavrentyev EN, Estes AM, Malik KU. Mechanism of high glucose induced angiotensin II production in rat vascular smooth muscle cells. Circ Res 101: 455-464, 2007.
54. Lavrentyev EN, Malik KU. High glucose-induced Nox1-derived superoxide downregulate PKC-betaII, which subsequently decreases ACE2 expression and ANG(1-7) formation in rat VSMCs. Am J Physiol Heart Circ Physiol 296: H106-H118, 2009.
55. Lee DK, Lanca AJ, Cheng R, Nguyen T, Ji XD, Gobeil F Jr, Chemtob S, George SR and O'Dowd BF. Agonist-independent nuclear localization of the Apelin, angiotensin AT1, and bradykinin B2 receptors. J Biol Chem 279: 7901-7908, 2004.
56. Li XC, Cook JL, Rubera I, Tauc M, Zhang F, Zhuo JL. Intrarenal transfer of an intracellular fluorescent fusion of angiotensin II selectively in proximal tubules increases blood pressure in rats and mice. Am J Physiol Renal Physiol 300: F1076-F1088, 2011.
57. Li XC, Navar LG, Shao Y, Zhuo JL. Genetic deletion of AT1a receptors attenuates intracellular accumulation of ANG II in the kidney of AT1a receptor-deficient mice. Am J Physiol Renal Physiol 293: F586-F593, 2007.
58. Li XC, Zhuo JL. Selective knockdown of AT1 receptors by RNA interference inhibits Val5-ANG II endocytosis and NHE-3 expression in immortalized rabbit proximal tubule cells. Am J Physiol Cell Physiol 293: C367-C378, 2007.
59. Li XC, Zhuo JL. In vivo regulation of AT1a receptor-mediated intracellular uptake of [125I]Val5-ANG II in the kidneys and adrenals of AT1a receptor-deficient mice. Am J Physiol Renal Physiol 294: F293-F302, 2008.
60. Li XC, Zhuo JL. Intracellular ANG II directly induces in vitro transcription of TGF-β1, MCP-1, and NHE-3 mRNAs in isolated rat renal cortical nuclei via activation of nuclear AT1a receptors. Am J Physiol Cell Physiol 294: C1034-C1045, 2008.
61. Licea H, Walters MR, Navar G. Renal nuclear angiotensin II receptors in normal and hypertensive rats. Acta Physiol Hungarica 89: 427-438, 2002.
62. Lu D, Yang H, Shaw G, Raizada MK. Angiotensin II-induced nuclear targeting of the angiotensin type 1 (AT1) receptor in brain neurons. Endocrinology 139: 365-375, 1998.
63. Mitchell KD, Bagatell SJ, Miller CS, Mouton CR, Seth DM, Mullins JJ. Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats. J Renin Angiotensin Aldosterone Syst 7: 74-86, 2006.
64. Modrall JG, Yamaleyeva LM, Bernstein KE, Chappell MC. Chronic angiotensin II infusion in ACE-/- mice regulates both angiotensin II sequestration and enhanced angiotensin I in the kidney (Abstract). Hypertension 44: 502, 2004.
65. Morinelli TA, Raymond JR, Baldys A, Yang Q, Lee MH, Luttrell L, Ullian ME. Identification of a putative nuclear localization sequence within ANG II AT(1A) receptor associated with nuclear activation. Am J Physiol Cell Physiol 292: C1398-C1408, 2007.
66. Navar LG, Kobori H, Prieto MC, Gonzalez-Villalobos RA. Intratu-bular renin-angiotensin system in hypertension. Hypertension 57: 355-362, 2011.
67. Nguyen G. Renin/prorenin receptors. Kidney Int 69: 1503-1506, 2006.
68. Nguyen G, Delarue F, Burckle C, Bouzhir L, Giller T, Sraer JD. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 109: 1417-1427, 2002.
69. Ozono R, Wang ZQ, Moore AF, Inagami T, Siragy HM, Carey RM. Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension 30: 1238-1246, 1997.
70. Paul M, Mehr AP, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 86: 747-803, 2006.
71. Pendergrass KD, Averill DB, Ferrario CM, Diz DI, Chappell MC. Differential expression of nuclear AT1 receptors and angiotensin II within the kidney of the male congenic mRen2. Lewis rat. Am J Physiol Renal Physiol 290: F1497-F1506, 2006.
72. Pendergrass KD, Gwathmey TM, Michalek RD, Grayson JM, Chap-pell MC. The angiotensin II-AT1 receptor stimulates reactive oxygen species within the cell nucleus. Biochem Biophys Res Commun 384: 149-154, 2009.
73. Pinheiro SV, Simoes Silva AC, Sampaio WO, de Paula RD, Mendes EP, Bontempo ED, Pesquero JB, Walther T, Alenina N, Bader M, Bleich M, Santos RA. Nonpeptide AVE 0991 is an angiotensin-(1-7) receptor Mas agonist in the mouse kidney. Hypertension 44: 490-496, 2004.
74. Planchon SM, Waite KA, Eng C. The nuclear affairs of PTEN. J Cell Sci 121: 249-253, 2008.
75. Pohl M, Kaminski H, Castrop H, Bader M, Himmerkus N, Bleich M, Bachmann S, Theilig F. Intrarenal renin angiotensin system revisited: role of megalin-dependent endocytosis along the proximal nephron. J Biol Chem 285: 41935-41946, 2010.
76. Re M, Pampillo M, Savard M, Dubuc C, McArdle CA, Millar RP, Conn PM, Gobeil F Jr., Bhattacharya M, Babwah AV. The human gonadotropin-releasing hormone type I receptor is a functional intracel-lular GPCR expressed on the nuclear membrane. PLoS One 5: e11489, 2010.
77. Re R. Intracellular renin-angiotensin system: the tip of the intracrine physiology iceberg. Am J Physiol Heart Circ Physiol 293: H905-H906, 2007.
78. Sadjadi J, Kramer GL, Yu CH, Welborn MB, Modrall JG. Angio-tensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism. J Surg Res 129: 272-277, 2005.
79. Sampaio WO, de Henrique CC, Santos RA, Schiffrin EL, Touyz RM. Angiotensin-(1-7) counter regulates angiotensin II signaling in human endothelial cells. Hypertension 50: 1093-1098, 2007.
80. Santos RA, Ferreira AJ, Simoes Silva AC. Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis. Exp Physiol 93: 519-527, 2008.
81. Santos RAS, Simoes Silva A, Maric C, Silva DMR, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SVB, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole-Santos MJ, Schultheiss HP, Speth R, Walther T. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci 100: 8258-8263, 2003.
82. Savard M, Barbaz D, Belanger S, Muller-Esterl W, Bkaily G, Or-leans-Juste P, Cote J, Bovenzi V, Gobeil F Jr. Expression of endogenous nuclear bradykinin B2 receptors mediating signaling in immediate early gene activation. J Cell Physiol 216: 234-244, 2008.
83. Schmid U, Stopper H, Schweda F, Queisser N, Schupp N. Angiotensin II induces DNA damage in the kidney. Cancer Res 68: 9239-9246, 2008.
84. Schupp N, Schmid U, Rutkowski P, Lakner U, Kanase N, Heidland A, Stopper H. Angiotensin II-induced genomic damage in renal cells can be prevented by angiotensin II type 1 receptor blockage or radical scavenging. Am J Physiol Renal Physiol 292: F1427-F1434, 2007.
85. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, Griendling KK. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res 91: 406-413, 2002.
86. Shaltout HA, Figueroa JP, Rose JC, Diz DI, Chappell MC. Alterations in circulatory and renal angiotensin-converting enzyme and angio-tensin-converting enzyme 2 in fetal programmed hypertension. Hypertension 53: 404-408, 2009.
87. Shaltout HA, Rose JC, Figueroa JP, Chappell MC, Diz DI, Averill DB. Acute AT(1)-receptor blockade reverses the hemodynamic and baroreflex impairment in adult sheep exposed to antenatal betametha-sone. Am J Physiol Heart Circ Physiol 299: H541-H547, 2010.
88. Shaltout HA, Westwood B, Averill DB, Ferrario CM, Figueroa J, Diz DI, Rose JC, Chappell MC. Angiotensin metabolism in renal proximal tubules, urine and serum of sheep: Evidence for ACE2-dependent processing of Angiotensin II. Am J Physiol Renal Physiol 292: F82-F91, 2007.
89. Sherrod M, Liu X, Zhang X, Sigmund CD. Nuclear localization of angiotensinogen in astrocytes. Am J Physiol Regul Integr Comp Physiol 288: R539-R546, 2005.
90. Singh VP, Le B, Bhat VB, Baker KM, Kumar R. High-glucose-induced regulation of intracellular ANG II synthesis and nuclear redistribution in cardiac myocytes. Am J Physiol Heart Circ Physiol 293: H939-H948, 2007.
91. Singh VP, Le B, Khode R, Baker KM, Kumar R. Intracellular angiotensin II production in diabetic rats is correlated with cardiomyo-cyte apoptosis, oxidative stress, and cardiac fibrosis. Diabetes 57: 3297-3306, 2008.
92. Spencer NY, Yan Z, Boudreau RL, Zhang Y, Luo M, Li Q, Tian X, Shah AM, Davisson RL, Davidson B, Banfi B, Engelhardt JF. Control of hepatic nuclear superoxide production by glucose 6-phosphate dehy-drogenase and NADPH oxidase-4. J Biol Chem 286: 8977-8987, 2011.
93. Steckelings UM, Larhed M, Hallberg A, Widdop RE, Jones ES, Wallinder C, Namsolleck P, Dahlof B, Unger T. Non-peptide AT2-receptor agonists. Curr Opin Pharmacol 11: 187-192, 2011.
94. Steckelings UM, Rompe F, Kaschina E, Unger T. The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets. Fundam Clin Pharmacol 23: 693-703, 2009.
95. Su Z, Zimpelmann J, Burns KD. Angiotensin-(1-7) inhibits angioten-sin II-stimulated phosphorylation of MAP kinases in proximal tubular cells. Kidney Int 69: 2212-2218, 2006.
96. Tadevosyan A, Maguy A, Villeneuve LR, Babin J, Bonnefoy A, Allen BG, Nattel S. Nuclear-delimited angiotensin receptor-mediated signaling regulates cardiomyocyte gene expression. J Biol Chem 285: 22338-22349, 2010.
97. Tang L, Carey LC, Bi J, Valego N, Sun X, Deibel P, Perrott J, Figueroa JP, Chappell MC, Rose JC. Gender differences in the effects of antenatal betamethasone exposure on renal function in adult sheep. Am J Physiol Regul Integr Comp Physiol 296: R309-R317, 2009.
98. Tang SS, Rogg H, Schumacher R, Dzau VJ. Characterization of nuclear angiotensin-II-binding sites in rat liver and comparison with plasma membrane receptors. Endocrinology 131: 374-380, 1992.
99. Thekkumkara T, Linas SL. Role of internalization in AT(1A) receptor function in proximal tubule epithelium. Am J Physiol Renal Physiol 282: F623-F629, 2002.
100. Thomas WG, Thekkumkara TJ, Baker KM. Molecular mechanisms of angiotensin II (AT1A) receptor endocytosis. Clin Exp Pharmacol Physiol Suppl 3: S74-S80, 1996.
101. Tigerstedt R, Bergman P. Niere und Kreislauf. Arch Physiol 8: 223-271, 1898.
102. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275: 33238-33243, 2000.
103. Wiemer G, Dobrucki LW, Louka FR, Malinski T, Heitsch H. AVE 0991, a nonpeptide mimic of the effects of angiotensin-(1-7) on the endothelium. Hypertension 40: 847-852, 2002.
104. Wilson BA, Gwathmey T, Pirro N, Chappell MC. Evidence for protein kinase C-dependent stimulation of reactive oxygen species in isolated nuclei of renal epithelial cells (Abstract). FASEB J 24: 1059.3, 2010.
105. Worman HJ, Foisner R. The nuclear envelope from basic biology to therapy. Biochem Soc Trans 38: 253-256, 2010.
106. Zhuo JL, Li XC. New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II. Peptides 32: 1551-1565, 2011.
107. 2+ mobilization by stimulating intracellular AT1 receptors in proximal tubule cells. Am J Physiol Renal Physiol 290: F1382-F1390, 2006.